Considering the significant involvement of both Tie2 and FGFR1 in tumor angiogenesis, it is plausible to assume that the synergistic inhibition of these two pathways may contribute to the remarkable antiangiogenic efficacy of brassinin [42]. Here, FGFR1 is linked to neoplasm.